EMA: Draft GL for OIPs [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2024-04-19 17:40 (31 d 11:22 ago) – Posting: # 23959
Views: 1,094

Dear all,

as a birthday gift the EMA published a

Draft guideline on the requirements for demonstrating therapeutic equivalence between orraly inhaled products (OIP) for asthma and chronic obstructive pulmonary disease (COPD).

Consultation is open until 30 October 2024.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
 Admin contact
23,033 posts in 4,835 threads, 1,647 registered users;
35 visitors (0 registered, 35 guests [including 7 identified bots]).
Forum time: 05:02 CEST (Europe/Vienna)

Give me a fruitful error any time, full of seeds, bursting with its own corrections.
You can keep your sterile truth for yourself.    Vilfredo Pareto

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz